People with severe gastrointestinal (GI) disorders, such as gastroparesis or inflammatory bowel disease, should also avoid GLP-1 agonists due to the possibility of exacerbating GI symptoms (23)
00:14:02 Vickie Danaher Keeping all this in mind, lets now circle back to our patient, Angela, and think about how wed actually approach the conversation with her in practice
However, independent lines of evidence continue to support involvement of FNDC5/irisin signaling in metabolic adaptation, bone remodeling, and neuroprotection, suggesting that early technical limitations may have obscured rather than invalidated its physiological relevance ( A key limitation for irisin translation remains the absence of a definitively identified receptor
The hormone acts through GLP-1 receptors (GLP-1R), which are G-protein coupled receptors distributed throughout the body, including various regions of the central nervous system